JP2009502914A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2009502914A5 JP2009502914A5 JP2008523847A JP2008523847A JP2009502914A5 JP 2009502914 A5 JP2009502914 A5 JP 2009502914A5 JP 2008523847 A JP2008523847 A JP 2008523847A JP 2008523847 A JP2008523847 A JP 2008523847A JP 2009502914 A5 JP2009502914 A5 JP 2009502914A5
- Authority
- JP
- Japan
- Prior art keywords
- disorders
- withdrawal
- substance
- withdrawal symptoms
- induced
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/US2005/026439 WO2007018496A1 (en) | 2005-07-26 | 2005-07-26 | Methods for treating substance-related disorders |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2009502914A JP2009502914A (ja) | 2009-01-29 |
| JP2009502914A5 true JP2009502914A5 (https=) | 2012-03-29 |
| JP5094720B2 JP5094720B2 (ja) | 2012-12-12 |
Family
ID=35064669
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2008523847A Expired - Fee Related JP5094720B2 (ja) | 2005-07-26 | 2005-07-26 | サブスタンス関連障害を処置する方法 |
Country Status (13)
| Country | Link |
|---|---|
| EP (1) | EP1928451B1 (https=) |
| JP (1) | JP5094720B2 (https=) |
| KR (1) | KR101199499B1 (https=) |
| CN (1) | CN101272776B (https=) |
| AT (1) | ATE538784T1 (https=) |
| AU (1) | AU2005335241B9 (https=) |
| BR (1) | BRPI0520451A2 (https=) |
| CA (1) | CA2616721C (https=) |
| EA (1) | EA019935B1 (https=) |
| ES (1) | ES2385087T3 (https=) |
| IL (1) | IL189003A0 (https=) |
| NO (1) | NO20080877L (https=) |
| WO (1) | WO2007018496A1 (https=) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1890684B1 (en) | 2005-06-08 | 2013-08-14 | SK Biopharmaceuticals Co., Ltd. | Treatment of sleep-wake disorders |
| KR20120098578A (ko) | 2009-06-22 | 2012-09-05 | 에스케이바이오팜 주식회사 | 피로의 치료 또는 예방 방법 |
| US8232315B2 (en) * | 2009-06-26 | 2012-07-31 | Sk Biopharmaceuticals Co., Ltd. | Methods for treating drug addiction and improving addiction-related behavior |
| EP2496227B1 (en) | 2009-11-06 | 2019-05-22 | SK Biopharmaceuticals Co., Ltd. | Methods for treating fibromyalgia syndrome |
| BR112012010670A2 (pt) | 2009-11-06 | 2016-04-12 | Sk Biopharmaceuticals Co Ltd | métodos para tratamento de distúrbio de défict de atenção/hiperatividade |
| US9610274B2 (en) | 2010-06-30 | 2017-04-04 | Sk Biopharmaceuticals Co., Ltd. | Methods for treating bipolar disorder |
| US8609849B1 (en) | 2010-11-30 | 2013-12-17 | Fox Chase Chemical Diversity Center, Inc. | Hydroxylated sulfamides exhibiting neuroprotective action and their method of use |
| CA2905457A1 (en) | 2013-03-13 | 2014-10-09 | Aerial Biopharma, Llc | Treatment of cataplexy |
| CA2917702A1 (en) | 2013-07-18 | 2015-01-22 | Jazz Pharmaceuticals International Iii Limited | Treatment for obesity |
| US10195151B2 (en) | 2016-09-06 | 2019-02-05 | Jazz Pharmaceuticals International Iii Limited | Formulations of (R)-2-amino-3-phenylpropyl carbamate |
| BR112019025286A2 (pt) | 2017-06-02 | 2020-06-23 | Jazz Pharmaceuticals Ireland Limited | Métodos e composições para tratamento de sonolência excessiva |
| US12502371B2 (en) | 2019-06-27 | 2025-12-23 | Numan Labo Llc | Drug for treating and preventing dementia |
| US10940133B1 (en) | 2020-03-19 | 2021-03-09 | Jazz Pharmaceuticals Ireland Limited | Methods of providing solriamfetol therapy to subjects with impaired renal function |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3313692A (en) * | 1958-04-21 | 1967-04-11 | Armour Pharma | Method of inducing calming and muscle relaxation with carbamates |
| EP1383489B1 (en) * | 2001-02-27 | 2007-05-09 | Ortho-Mcneil Pharmaceutical, Inc. | Carbamate compounds for use in preventing or treating neurodegenerative disorders |
| US7122576B2 (en) * | 2001-02-27 | 2006-10-17 | Plata-Salaman Carlos R | Carbamate compounds for use in preventing or treating bipolar disorder |
| KR100886578B1 (ko) * | 2001-02-27 | 2009-03-05 | 오르토-맥네일 파마슈티칼, 인코퍼레이티드 | 카바메이트 화합물을 포함하는 정신증 장애 예방용 또는 치료용 약제학적 조성물 |
| PT1411917E (pt) * | 2001-02-27 | 2007-09-17 | Ortho Mcneil Pharm Inc | ''compostos carbamatos para utilização na prevenção ou tratamento de distúrbios do movimento'' |
| US20070021500A1 (en) * | 2005-07-12 | 2007-01-25 | Twyman Roy E | Methods for neuroprotection |
-
2005
- 2005-07-26 ES ES05775692T patent/ES2385087T3/es not_active Expired - Lifetime
- 2005-07-26 CN CN200580051664XA patent/CN101272776B/zh not_active Expired - Fee Related
- 2005-07-26 KR KR1020087004533A patent/KR101199499B1/ko not_active Expired - Lifetime
- 2005-07-26 BR BRPI0520451-8A patent/BRPI0520451A2/pt not_active Application Discontinuation
- 2005-07-26 AT AT05775692T patent/ATE538784T1/de active
- 2005-07-26 WO PCT/US2005/026439 patent/WO2007018496A1/en not_active Ceased
- 2005-07-26 JP JP2008523847A patent/JP5094720B2/ja not_active Expired - Fee Related
- 2005-07-26 CA CA2616721A patent/CA2616721C/en not_active Expired - Lifetime
- 2005-07-26 EP EP05775692A patent/EP1928451B1/en not_active Expired - Lifetime
- 2005-07-26 AU AU2005335241A patent/AU2005335241B9/en not_active Ceased
- 2005-07-26 EA EA200800422A patent/EA019935B1/ru not_active IP Right Cessation
-
2008
- 2008-01-24 IL IL189003A patent/IL189003A0/en unknown
- 2008-02-19 NO NO20080877A patent/NO20080877L/no not_active Application Discontinuation
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2009502914A5 (https=) | ||
| Dome et al. | Smoking, nicotine and neuropsychiatric disorders | |
| Murray et al. | Insomnia caused by serotonin depletion is due to hypothermia | |
| Scammell et al. | Orexin receptors: pharmacology and therapeutic opportunities | |
| Angelucci et al. | Investigating the neurobiology of music: brain-derived neurotrophic factor modulation in the hippocampus of young adult mice | |
| Karila et al. | GHB and synthetic cathinones: clinical effects and potential consequences | |
| JP6421185B2 (ja) | ベンゾイミダゾール−プロリン誘導体の使用 | |
| JP2009513672A5 (https=) | ||
| JP2007523178A5 (https=) | ||
| AU2021206771B2 (en) | Cognitive disorder prevention and therapy | |
| JP2017535612A5 (https=) | ||
| JP2005523335A5 (https=) | ||
| WO2008048410A3 (en) | Diagnostic methods and genetic markers for alzheimer disease | |
| Niaura et al. | Varenicline | |
| JP2019511548A5 (https=) | ||
| CN117500788A (zh) | 作为血清素能药物的用于治疗与之相关的疾病的吲哚衍生物 | |
| Szily et al. | Designer drugs in psychiatric practice-a review of the literature and the recent situation in Hungary | |
| Manconi et al. | Pramipexole versus ropinirole: polysomnographic acute effects in restless legs syndrome | |
| Breuer et al. | “Herbal seizures”–atypical symptoms after ibogaine intoxication: a case report | |
| JP2008526706A5 (https=) | ||
| Kjellgren et al. | The quest for well-being and pleasure: experiences of the novel synthetic opioids AH-7921 and MT-45, as reported by anonymous users online. | |
| JP2010505919A5 (https=) | ||
| CA2672920A1 (en) | Aryl piperazine derivatives useful for the treatment of neuropsychiatric disorders | |
| JP2006519251A5 (https=) | ||
| Patel et al. | Effect of alcohol on brain development |